Apollo Endo

Developer of therapeutic devices for obesity and other GI disorders

placeAustin, Texas, United States calendar_todayFounded 2005 groups132 employees language apolloendo.com

Registered entities

Investor mix

10 investors on record; lead investors include Remeditex, HIG BioHealth Partners, Novo Holdings; 2 have since exited.

Investor typeCountShare
Venture capital330%
Private equity110%
Other / undisclosed660%
Coming soon